The two most common prostate diseases by far are prostatitis and benign hyperplasia (BPH). Prostatitis can be complicated by BPH or it can be accompanied by periodic exacerbations. Drug therapy is an important part of the overall treatment of prostate diseases. In addition, treatment often ends in defeat due to incorrect therapy, missed medication and, when the condition is alleviated, ignoring the disease.
For example, 20-30% of patients are not satisfied with the treatment, do not feel a decrease in symptoms of urinary tract diseases and an improvement in their quality of life. This is most likely due to an incorrect assessment of lower urinary tract function in men with BPH and, accordingly, the choice of inadequate treatment.
As you know, prostatitis is acute and chronic (CP), bacterial and abacterial.
Prostatitis in%
- acute bacterial prostatitis - 5-10%;
- chronic bacterial prostatitis - 6-10%;
- chronic abacterial prostatitis - 80–90%, including prostatodynia - 20–30%.
The most common is chronic abacterial prostatitis, which must be controlled and timely prevented exacerbations with and without BPH.
The main drugs used to treat BPH and chronic prostatitis:
- 5a-reductase inhibitors (finasteride, dutasteride);
- α-blockers (doxazosin, tamsulosin);
- Phytotherapy (sabal palm extract);
- Antibiotics;
- Amino acid complexes;
- animal organ extracts (prostate extract);
- Entomotherapy drugs (products derived from insects).
At the same time, in 13-30% of the effect of the use of α-blockers does not appear within 3 months after treatment - further therapy with drugs of this group is not advisable.
When prescribing finasteride, the doctor must be prepared for the fact that the main side effects of the drug: impotence, decreased libido, decrease in the volume of ejaculate, can lead to the patient's self-withdrawal of the drug.
Treatment of BPH and prostatitis is an important urological problem that has not yet been fully resolved.
Frequent exacerbations of CP without any indications for surgery on the prostate will force the doctor to use additional methods of drug treatment. Often, the presence of accompanying CP exacerbates the course of BPH because inflammation occurs in 80% of cases in the prostate with benign hyperplasia.
Modern medicine offers us new ways to treat CP and BPH and prevent exacerbations.